High-dose midazolam therapy for refractory status epilepticus in children
- 15 September 2006
- journal article
- clinical trial
- Published by Springer Nature in Intensive Care Medicine
- Vol. 32 (12) , 2070-2076
Abstract
Objective To assess the efficacy of high-dose midazolam in the treatment of refractory status epilepticus in children. Setting Paediatric intensive care unit (PICU). Design Audit of clinical experience. Subjects Seventeen consecutive patients treated for episodes of refractory status epilepticus. Interventions Algorithm-driven administration of intravenous midazolam to control RSE. Regular, mandatory, patient evaluation to avoid delay in the appropriate escalation of therapy. Our target was the abolition of clinical seizures within 30 min of initiating treatment and early confirmation of cessation of all seizure activity using EEG. The algorithm had failed if clinical seizures persisted beyond 30 min despite the administration of midazolam at 24 μg/kg/min or if administration of a further acute anti-epileptic drug was required to achieve seizure control. Measurements The midazolam infusion rate, cumulative midazolam dose and duration of midazolam therapy at time of clinical seizure control were recorded. Haemodynamic parameters were recorded continuously. Episodes of algorithm failure, breakthrough seizures and seizure relapses were identified. Patient outcome was measured in terms of survival to PICU discharge. Results In 13 patients (76%) midazolam achieved clinical seizure control within 30 min of treatment initiation. Midazolam was eventually successful in treating 15 seizure episodes (88%). Breakthrough seizures occurred in 8 patients (47%). Relapse after discontinuation of therapy occurred in 1 patient (6%). No significant adverse effects attributable to the use of midazolam occurred. There were 3 deaths (18%) related to underlying CNS pathology. Conclusions Midazolam can offer control of refractory status epilepticus without significant morbidity.Keywords
This publication has 13 references indexed in Scilit:
- Paradoxical reaction following intravenous midazolam premedication in pediatric patients – a randomized placebo controlled trial of ketamine for rapid tranquilizationPediatric Anesthesia, 2004
- Continuous EEG monitoring and midazolam infusion for refractory nonconvulsive status epilepticusNeurology, 2001
- The treatment of convulsive status epilepticus in childrenArchives of Disease in Childhood, 2000
- Complications and Costs of Treatment of Refractory Generalized Convulsive Status Epilepticus in ChildrenJournal of Child Neurology, 1999
- Efficacy and Mortality in Treatment of Refractory Generalized Convulsive Status Epilepticus in Children: A Meta-AnalysisJournal of Child Neurology, 1999
- Midazolam coma for refractory status epilepticus in childrenCritical Care Medicine, 1999
- Status epilepticus on the paediatric intensive care unit—the role of EEG monitoringSeizure: European Journal of Epilepsy, 1999
- Complications of sedation with midazolam in the intensive care unit and a comparison with other sedative regimensCritical Care Medicine, 1998
- Continuous midazolam infusion as treatment of status epilepticusArchives of Disease in Childhood, 1997
- Midazolam in the treatment of status epilepticus in childrenCritical Care Medicine, 1993